ReShape Lifesciences Inc Working Capital to Net Assets Ratio
ReShape Lifesciences Inc working capital to net assets ratio. ReShape Lifesciences Inc (RSLS) has a Working Capital to Net Assets ratio of 97.2% as of June 2025. Working capital of $5.66 Million (current assets of $8.86 Million minus current liabilities of $3.20 Million) is measured against net assets of $5.83 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ReShape Lifesciences Inc (RSLS) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of ReShape Lifesciences Inc (2005–2024)
Working capital to net assets ratio of ReShape Lifesciences Inc from 2005 to 2024. This chart shows how ReShape Lifesciences Inc's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2024. As of June 2025, the ratio stands at 97.2%, reflecting working capital of $5.66 Million against net assets of $5.83 Million USD. See RSLS days of operational coverage to measure how many days the company can operate on defensive assets alone.
ReShape Lifesciences Inc Working Capital to Net Assets Ratio by Year (2005–2024)
ReShape Lifesciences Inc working capital to net assets ratio by year from 2005 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for ReShape Lifesciences Inc from 2005 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ReShape Lifesciences Inc (RSLS) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 156.9% | $-397.00K | $-253.00K | $4.59 Million | $4.99 Million | ▲ +59.1 pp |
| 2023 | 97.8% | $6.52 Million | $6.66 Million | $10.30 Million | $3.78 Million | ▲ +31.5 pp |
| 2022 | 66.4% | $2.43 Million | $3.66 Million | $9.91 Million | $7.48 Million | ▲ +17.7 pp |
| 2021 | 48.6% | $22.41 Million | $46.07 Million | $29.94 Million | $7.53 Million | ▲ +67.0 pp |
| 2020 | -18.4% | $-2.66 Million | $14.49 Million | $8.94 Million | $11.61 Million | ▼ -17.2 pp |
| 2019 | -1.2% | $-281.00K | $24.11 Million | $10.11 Million | $10.39 Million | ▼ -2.3 pp |
| 2018 | 1.1% | $356.49K | $31.66 Million | $8.72 Million | $8.36 Million | ▼ -15.7 pp |
| 2017 | 16.8% | $12.85 Million | $76.37 Million | $13.94 Million | $1.09 Million | ▼ -133.2 pp |
| 2016 | 150.0% | $4.41 Million | $2.94 Million | $5.72 Million | $1.31 Million | ▼ -13.8 pp |
| 2015 | 163.8% | $6.02 Million | $3.67 Million | $10.50 Million | $4.49 Million | ▲ +19.0 pp |
| 2014 | 144.8% | $9.65 Million | $6.66 Million | $13.02 Million | $3.38 Million | ▼ -24.6 pp |
| 2013 | 169.4% | $24.86 Million | $14.68 Million | $24.99 Million | $127.00K | ▲ +27.3 pp |
| 2012 | 142.0% | $16.87 Million | $11.88 Million | $24.40 Million | $7.54 Million | ▲ +32.2 pp |
| 2011 | 109.8% | $22.00 Million | $20.04 Million | $31.57 Million | $9.56 Million | ▲ +2.8 pp |
| 2010 | 107.0% | $31.77 Million | $29.71 Million | $37.80 Million | $6.03 Million | ▼ -163.0 pp |
| 2009 | 270.0% | $15.07 Million | $5.58 Million | $15.10 Million | $34.00K | ▲ +86.6 pp |
| 2008 | 183.4% | $20.92 Million | $11.41 Million | $26.79 Million | $5.88 Million | ▲ +73.4 pp |
| 2007 | 110.0% | $49.80 Million | $45.28 Million | $57.55 Million | $7.75 Million | ▲ +5.3 pp |
| 2006 | 104.7% | $29.92 Million | $28.57 Million | $34.96 Million | $5.03 Million | ▼ -332.8 pp |
| 2005 | 437.6% | $8.64 Million | $1.97 Million | $10.88 Million | $2.24 Million | — |